{"id":6161,"date":"2025-12-19T12:45:52","date_gmt":"2025-12-19T12:45:52","guid":{"rendered":"https:\/\/www.paytmmoney.com\/blog\/?p=6161"},"modified":"2025-12-23T03:46:38","modified_gmt":"2025-12-23T03:46:38","slug":"nifty-back-on-its-feet-at-25966-shriram-finance-max-healthcare-among-top-gainers","status":"publish","type":"post","link":"https:\/\/www.paytmmoney.com\/blog\/nifty-back-on-its-feet-at-25966-shriram-finance-max-healthcare-among-top-gainers\/","title":{"rendered":"Nifty Back on Its Feet at 25,966; Shriram Finance, Max Healthcare Among Top Gainers"},"content":{"rendered":"

On Friday, December 19, 2025, the Indian stock market delivered a spectacular performance as the Nifty 50 reclaimed the key 25,950 level, ending a four-day losing streak. Investor sentiment was boosted by a flurry of deals and robust institutional buying, with Shriram Finance and Max Healthcare emerging as the star Nifty performers of the day.<\/span><\/p>\n

The recovery on D-Street was broad-based, with the Sensex jumping 447.55 points or 0.53% to close at 84,929.36. The Nifty 50 followed suit, gaining 150.90 points or 0.58% to end at 25,966.40. This rally was supported by a healthy market breadth of 41:09, indicating that for every nine stocks that declined, forty-one advanced.<\/span><\/p>\n

Shriram Finance Hits Historic Highs<\/b><\/h2>\n

The primary driver of the day’s optimism was Shriram Finance. The <\/span>Shriram Finance share price<\/span><\/a> witnessed intense buying interest, surging 4.10% to close at \u20b9905.10. During the session, the stock scaled a fresh 52-week high of \u20b9913.50.<\/span><\/p>\n

This surge was fuelled by news that Japan\u2019s MUFG is set to acquire a 20% stake in the company for approximately $4.45 billion (\u20b939,600 crore). This represents the largest cross-border investment in India\u2019s financial sector to date.<\/span><\/p>\n

(<\/span><\/i>Source:<\/i><\/b> Livemint)<\/span><\/i><\/span><\/p>\n

Healthcare and Infrastructure Giants Surge<\/b><\/h2>\n

Max Healthcare<\/span><\/a> also played a pivotal role in the Nifty’s recovery. The stock rose 2.62% to finish at \u20b91,076.00, following the board’s approval of a \u20b91,020 crore investment to build a new 450-bed super speciality hospital in Pune.<\/span><\/p>\n

Other notable gainers included:<\/span><\/p>\n